期刊文献+

2′,4″-O-二(三甲基硅)红霉素A肟的合成研究 被引量:2

Synthetic study of 2′,4″-O-bis(trimethylsilyl)erythromycin A oxime
暂未订购
导出
摘要 目的深入研究 2′ ,4″ O 二 (三甲基硅 )红霉素A肟 (EMAO)的合成反应。方法通过对反应过程的监测和产品分析 ,考察溶剂、硅烷化试剂、催化剂对反应的影响 ,研究Z、E异构体的反应活性。结果反应可在室温下进行 ,CH3 CN作溶剂最好 ,用量是EMAO的 5~ 6倍 (体积与质量比 ) ;硅烷化试剂HMDS为EMAO的 3倍摩尔质量较好 ;催化剂Py·HCl和NH4Cl分别为EMAO的 0 3~ 0 5倍和 1 2~ 1 5倍摩尔质量较好。产品收率达 95 % ,纯度达 90 %。结论EMAO的 2′、4″位的两个羟基硅烷化反应是分步进行的 ,反应活性E EMAO大于Z EMAO。 Aim To investigate the synthesis of 2′,4″-O-bis(trimethylsilyl)erythromycin A oxime.Method The influence of the solvent,silylating reagent and catalyzer to the reaction was probed under the inspection of the reactive process and analysis of products.The reactivity of Z,E isomer was detected.Result The reaction can be carried out under room temperature in the best solvent CH_3CN with a 5~6 times of EMAO(volume∶mass).The best mol.ratio between HMDS and EMAO is n(EMAO)∶n(HMDS)=1∶3;catalyzer can be Py·HCl,NH_4Cl or HCO_2H,better mol.ratios the are n(Py·HCl)∶n(EMAO)=1∶0.3~0.5 and n(NH_4Cl)∶n(EMAO)=1∶1.2~1.5.The structure of the product was identified.The yield and purity of the product reached more than 95% and 90%.Conclusion The silylating reaction is not proceeding together at 2′,4″-hydroxyl position and the reactivity of E-EMAO is better than that of Z-EMAO.The yield and purity show a significant improvement by using optimized synthetic reactive conditions.
出处 《中国药物化学杂志》 CAS CSCD 2004年第3期150-153,共4页 Chinese Journal of Medicinal Chemistry
基金 国家经贸委技术创新基金 (0 1BK - 0 0 9) 河北师范大学青年基金 (2 0 0 2 0 8)
关键词 药物化学 制备 化学合成 2′ 4″-O-二(三甲基硅)红霉素A肟 异构体 medicinal chemistry preparation chemical synthesis 2′,4″-O-bis(trimethylsilyl)erythromycin A oxime isomer
  • 相关文献

参考文献8

  • 1Gustafsson I,Hjelm E,Cars O.In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647(telithromycin)against Chlamydia pneumoniae[J].Antimicro Agents Chemother,2000,44(8):1846-1849.
  • 2Allevi P,Longo A,Anastasia M.A new convenient transformation of erythromycin A into clarithromycin[J].J Med Chem,1999,7(12):2749-2752.
  • 3Suh KH,Kim ND,Pae HJ,et al.Erythromycin A compounds and process for preparing the same[P].US:6528628,2003-03-04.
  • 4Ku YY.9-Oximesilyl erythromycin A derivatives[P].US:5837829,1998-12-17.
  • 5Sun Jing-guo,Yao Guo-wei,Ou Yu-xiang.The comparative process for the preparation of 9-oxime erythromycin A[J].J Beijing Institute Technol,2004,13(1):76-79.
  • 6Leo AP.Encyclopedia of reagents organic synthesis[M].New York:John Wiley&Sons Ltd.,1995.2661-2662.
  • 7孙京国,梁建华,邓志华,姚国伟.克拉霉素的合成进展[J].有机化学,2002,22(12):951-963. 被引量:29
  • 8孙京国,姚国伟.红霉素肟及相关化合物的高效液相色谱分析[J].分析化学,2003,31(9):1089-1092. 被引量:11

二级参考文献79

  • 1马舒冰.红霉素衍生物的半合成及构效关系[J].国外医药(抗生素分册),1996,17(1):33-37. 被引量:5
  • 2Sun Jingguo(孙京国) Liang Jianhua(梁建华) Deng Zhihua(志华) Yao Guowei(姚国伟).Chinese Journal of Organic Chemistry(有机化学),2002,22(12):951-963.
  • 3Sun Jingguo(孙京国 ).Academic Conference of China Association for Science and Technology in 2001(2001中国科技年会)[M].,2001.1524.
  • 4Clark R F, Ma Z K, Wang S Y, Gfiesgraber G, Tufano M, Yong H, Li LP, Zhang X L,Nilius A M, Chu D T W. Bioorganic & Medicinal Chemistry Letters, 2000, 10:815 - 819.
  • 5Morimoto S, Adaehi T, Matsunaga T, Kashimura M, Watanabe Y, Sota K. U. S.Patent, 6342590 B1, 2002.
  • 6Takehiro A, Masaml G, Kkazuto S, Tomomichi Y, Masahiro H. U.S.Patent, 5274085, 1993.
  • 7Willkening R R. U.S. Patent, 5912331, 1999.
  • 8Harang'V, Westedund D. Chromatographia, 1999, 50(9-10) :525 - 531.
  • 9Moheb M N, Terry J T. Journal of Liquid Chromatography & Related Technology, 1997,20(4):553 - 565.
  • 10Chieko T, Hisakazu O, Erika H, Hajime K, Hitoshi S, Tatsuji I.Journal of Chromozography B, 2000, 783:405 - 411.

共引文献35

同被引文献14

  • 1孙京国,冯玉玲.红霉素A9(O-叔丁基二甲基硅)肟的合成[J].精细化工,2007,24(2):162-165. 被引量:3
  • 2孙京国.三苯基氯硅烷对红霉素A肟的保护研究[J].河北师范大学学报(自然科学版),2007,31(3):359-364. 被引量:3
  • 3ERNESTO B, DULCE M M, FRANCISCO P,et al. Preparation of clarithromycin, selective 6-O-methylation of the novel erythromycin A 9-O-( 2-pyrimidyl ) oxime [ J ]. Tetrahedron Letters ,2007,48 ( 8 ) : 1321-1324.
  • 4ALLEVI P, LONGO A, Anastasia M. A new convenient transformation of erythromycin A into clarithromycin [ J ]. J Med Chem, 1999,7 ( 12 ) :2749-2752.
  • 5DILEK D, VIKTORYA A, CANAN B. Modeling the selective methylation in the synthesis of clarithromycin [ J ]. J Chem Soc Perkin Trans 2, 2002:6704575.
  • 6CLARK R F,MA Z K,WANG S,et al. Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivative [ J ]. Bioor Med Chem Lett,2000,10(8) : 815-819.
  • 7KU Y Y. 9-oximesilyl erythromycin A derivatives[ P]. US: 5 837 829,1998-11-17.
  • 8STATE FOOD and DRUG ADMINISTRATION. Guidance Principle of Medicine Research Technical (药物研究技术指导原则)[M].Beijing: Chin Med Science and Technology Press,2006:9-13.
  • 9SUN J G,YAO G W, OU Y X. The comparative Process for the Preparation of 9-Oxime Erythromycin A [ J ]. Journal of Beijing Institue of Technology, 2004,13 ( 1 ) :76-79.
  • 10张森林,曹胜华.酮内酯类抗生素——泰利霉素和喹红霉素的化学合成[J].中国抗生素杂志,2009,34(12):709-716. 被引量:3

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部